DXR תוצאה פיננסית נקייה daxor.com

סמלים רשמיים של חברת Daxor (DXR)

Daxor Corporation margins are based on the expansion of B2B sales of BVA-100 analyzers within US clinics. The company's net profit on this chart reflects earnings dynamics, where 0.01 represents the current level of the indicator. The production of critical diagnostic equipment ensures a stable income. The brand's environmental profile is limited to basic control over the disposal of electronic components.

Daxor Corporation (DXR) - רווח נקי מ-04.07.2022 עד 31.10.2026
מוצר עיקרי של Daxor Corp

Investors must evaluate a company's net income as the final financial result after deducting all operating expenses and taxes to avoid purchasing overvalued assets at the peak of the cycle. The positive trend on this chart reflects the effective commercialization of blood analysis systems developed by a dedicated staff of scientists and engineers, confirming the fundamental stability of the Daxor Corporation business.